Yuyuan Liu
Suzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Exploring the Molecular Mechanism of Hydroxychloroquine Against IgAN Through Network Pharmacology, MD Simulations and Experimental Assessment.
Journal: Journal of cellular and molecular medicine
Published: October 21, 2024
The protective mechanism of Dehydromiltirone in diabetic kidney disease is revealed through network pharmacology and experimental validation.
Journal: Frontiers in pharmacology
Published: April 06, 2023
Investigating the effect of dehydromiltirone on septic AKI using a network pharmacology method, molecular docking, and experimental validation.
Journal: Frontiers in pharmacology
Published: January 16, 2023
Glutamate ionotropic receptor NMDA type subunit 1: A novel potential protein target of dapagliflozin against renal interstitial fibrosis.
Journal: European journal of pharmacology
Published: December 20, 2022
Investigation into the effect and mechanism of dapagliflozin against renal interstitial fibrosis based on transcriptome and network pharmacology.
Journal: International immunopharmacology
Published: July 18, 2022
miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1.
Journal: Biochemical and biophysical research communications
Published: October 07, 2020
c‑Jun N‑terminal kinase/transforming growth factor‑β/Smad3 pathway: Is it associated with endoplasmic reticulum stress‑mediated renal interstitial fibrosis?
Journal: Molecular medicine reports
Published: August 07, 2018
Clinical and pathological analysis of IgA nephropathy with chronic renal failure.
Journal: Renal failure
Published: August 26, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026